Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
ChinaIPO:
05 August 2021Website:
http://www.yishengbio.comNext earnings report:
15 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 20 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
YS Latest News
YS Biopharma Co., Ltd. (NASDAQ:YS ) Q3 2024 Earnings Conference Call on April 19, 2024 at 8:00 AM ET. Company Participants include Alyssa Li - Director of Investor Relations, David Shao - President & CEO, Zenaida Mojares - Chief Medical Officer, Brenda Wu - CFO. Conference Call Participants include Hunter Diamond from Diamond Equity Research. Operator thanks everyone for joining YS Biopharma's Earnings Call for the First Nine Months of Fiscal Year 2024.
YS Biopharma (NASDAQ: YS ) stock is rising higher on Friday after the biopharmaceutical company announced officers purchasing shares. According to a press release, the company's founder and chairperson, Yi Zhang, as well as its director, president and CEO Hui Shao, are behind the share purchase.
YS Biopharma (NASDAQ: YS ) stock is rising higher on Friday after the biopharmaceutical company announced officers purchasing shares. According to a press release, the company's founder and chairperson, Yi Zhang, as well as its director, president and CEO Hui Shao, are behind the share purchase.
YS Biopharma (NASDAQ: YS ) stock is on the rise Tuesday as investors await positive news from a conference taking place today. This is the Global Select Spotlight Emerging Growth Invitational Investor Conference.
What type of business is YS Biopharma Co?
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
What sector is YS Biopharma Co in?
YS Biopharma Co is in the Healthcare sector
What industry is YS Biopharma Co in?
YS Biopharma Co is in the Biotechnology industry
What country is YS Biopharma Co from?
YS Biopharma Co is headquartered in China
When did YS Biopharma Co go public?
YS Biopharma Co initial public offering (IPO) was on 05 August 2021
What is YS Biopharma Co website?
https://www.yishengbio.com
Is YS Biopharma Co in the S&P 500?
No, YS Biopharma Co is not included in the S&P 500 index
Is YS Biopharma Co in the NASDAQ 100?
No, YS Biopharma Co is not included in the NASDAQ 100 index
Is YS Biopharma Co in the Dow Jones?
No, YS Biopharma Co is not included in the Dow Jones index
When does YS Biopharma Co report earnings?
The next expected earnings date for YS Biopharma Co is 15 August 2024